Invention Grant
- Patent Title: Diacylglycerol acyl transferase 2 inhibitors
-
Application No.: US17345064Application Date: 2021-06-11
-
Publication No.: US11866425B2Publication Date: 2024-01-09
- Inventor: Markus Boehm , Shawn Cabral , Matthew S. Dowling , Kentaro Futatsugi , Kim Huard , Esther Cheng Yin Lee , Allyn T. Londregan , Jana Polivkova , David A. Price , Qifang Li
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Zhigang Rao
- Main IPC: A61K31/505
- IPC: A61K31/505 ; A61P3/00 ; A61P3/10 ; A61P3/06 ; C07D405/14 ; C07D401/14 ; A61K31/506 ; A61K45/06 ; C07D409/14
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US20210309646A1 DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS Public/Granted day:2021-10-07
Information query
